OnKure Therapeutics (OKUR) Long-Term Debt Issuances (2020 - 2021)
OnKure Therapeutics' (OKUR) quarterly Long-Term Debt Issuances came in at $47.3 million in Q1 2021, little changed on a QoQ basis from $47.4 million in Q4 2020.
OnKure Therapeutics (OKUR) Long-Term Debt Issuances (2020 - 2021) Analysis & Trends
OnKure Therapeutics (OKUR) has 2 years of Long-Term Debt Issuances data on file, last reported at $47.3 million in Q1 2021.
- Quarterly Long-Term Debt Issuances changed N/A year-over-year to $47.3 million in Q1 2021, while the trailing twelve-month figure through Dec 2024 was $94.7 million (changed N/A YoY) and the FY2024 annual result came in at $6.0 million, changed N/A from the prior year.
- Long-Term Debt Issuances was little changed at $47.3 million in Q1 2021, from $47.4 million in the prior quarter.
- In the past five years, Long-Term Debt Issuances ranged from a high of $47.4 million in Q4 2020 to a low of $47.3 million in Q1 2021.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Long-Term Debt Issuances (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | OnKure Therapeutics | 195.74 Mn | 19.35 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2021 | 47.26 Mn |
| Mar 31, 2021 | 47.26 Mn |
| Dec 31, 2020 | 47.40 Mn |
| Dec 31, 2020 | 47.40 Mn |